Home Noticias de Salud Family Centers Health Centers Resources My Health Manager
  Search
  PersonalMD Services  
  Family Health
  Women's Health
  Children's Health
  Men's Health
  Senior's Health
   
  Health Centers
  Alternative Medicine
  Cardiac Care Center
  Cancer Center
  Emergency Dept
  Medical Advances
  Nutrition Central
  Pulmonary Center
  Sports Medicine
  Travel Medicine
   
  Resources
  Drug Interaction
  Drugs & Medications
  Health Encyclopedia


     
   
FDA to examine switch to over-the-counter sale for some chronic ailment

WASHINGTON, June 28 - Public hearings are set to start Wednesday, as the Food and Drug Administration considers whether to switch a number of prescription-only drugs to over-the-counter sale, The New York Times reported.

Evidence given during Wednesday and Thursday's hearings could see a number of medicines -- possibly including antibiotics and birth control pills -- go on sale without a doctor's prescription, the newspaper said in an article Wednesday.

The FDA next month is also due to convene a panel of scientific experts to evaluate applications from two drug manufacturers, Merck and Bristol-Myers Squibb, for low-dose versions of their anti-cholesterol pills to be sold over the counter.

This week's hearings will see the FDA make its first re-examination since 1972 of how it regulates over-the-counter drugs, The New York Times said.

The last review saw the FDA create a new system for approving over-the-counter drugs, in which more than 600 drugs were transferred from prescription to non-prescription status.

This time round, the FDA will examine whether patients with conditions more serious than mild headache or athlete's foot should be able to treat themselves.

The agency will now question whether more chronic conditions like high blood pressure, high cholesterol, and osteoporosis, should be treated by the patient.

"The health care environment has changed tremendously in recent years," Robert DeLap, the agency official heading the review was reported as saying.

"People are much more interested in self-care, and in being able to manage their minor conditions themselves."

The decision could have a major impact on the 100 billion-dollar pharmaceutical industry. It coincides with a political debate in Congress analysing who should pay for medicines and how much they should cost.

Some 55 people will testify at this week's hearings including drug and insurance company officials, safety advocates and infectious disease specialists.

The latter are concerned about antibiotic resistance.

Meanwhile, opponents to abortion are currently fighting over-the-counter sale of a birth control pill, which, taken in high doses can be used as a morning-after contraceptive, the newspaper added.


DISCUSSION
See what PersonalMD members have to say about this article.
 

 

 

 

Register About Us Emergency Contact us Privacy Policy Help Center
Resources Health Centers Family Health